Online Learning

A printed, recorded, or computer-presented activity that endures over a specified time and does not have a specific time or location designated for participation; rather, the participant determines whether and when to complete the activity.

Return to Search Options

26 matches found

Title	Type
FDA’s Role in Postmarketing Drug Safety Surveillance	Enduring Material
How FDA and ISMP Utilize Medication Error Reports to Improve Drug Safety	Enduring Material
Overview of Expanded Access (EA) Program and EA eRequest Site	Enduring Material
Biosimilar and Interchangeable Biosimilars: Review of Scientific Concepts, Case Studies, and Resources	Enduring Material
Fraudulent Products – Hidden Ingredients and Unproven Claims in Products Marketed as Dietary Supplements	Enduring Material
Enhanced Drug Distribution Security: 2023 and Beyond	Enduring Material
Safety Labeling Changes for Leukotriene Receptor Antagonists and Decisions Behind a Boxed Warning	Enduring Material
Project Facilitate: Oncology Expanded Access Program Update	Enduring Material
FDA’s Office of Orphan Products Development (OOPD) – An Overview and Update	Enduring Material
The Ins and Outs of Prescription Drug Labeling	Enduring Material
Orange Book: Frequently Asked Questions and Answers	Enduring Material
Counseling Patients on Generic Drugs	Enduring Material
Labeling Made Simple: The How, What, and Where of Drug Interactions in Prescribing Information	Enduring Material
An Overview of Naloxone and FDA’s Efforts to Expand Access	Enduring Material
Overview of Risk Evaluation and Mitigation Strategies (REMS) for Health Care Providers	Enduring Material
Pregnancy and Lactation Medication Information for the Healthcare Provider	Enduring Material
FDA Drug Information Resources and Applicability to Health Care Professionals	Enduring Material
Reporting and Public Viewing of Individual Case Safety Reports (ICSRs)	Enduring Material
Drug Shortages: Root Causes and Potential Solutions	Enduring Material
Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation -- Enduring Material	Enduring Material
Development and U.S. Regulation of Preventive Vaccines	Enduring Material
Understanding Generic Narrow Therapeutic Index Drugs	Enduring Material
The Safety Evaluation and Surveillance of Generic Drugs	Enduring Material
Frequently Asked Questions about Labeling for Prescription Medicines	Enduring Material
Assessment of Stromal Tumor-Infiltrating Lymphocytes	Enduring Material
PCOS Revisited: Diagnosis, Management, and Future Needs	Enduring Material
Back To Top

This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.

This system is provided for Government-authorized use only.

Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.

Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.

By using this system, you understand and consent to the following:

The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.

Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.